{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:03:47Z","timestamp":1772741027178,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T22:57:35Z","timestamp":1457996255000},"page":"2092-2095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Tafuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-8239","authenticated-orcid":false,"given":"M.F.","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Germinario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.011_bib0130","series-title":"Health21: the health for all policy for the WHO European Region (European Health for All Series, No.6)","year":"1999"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0135","first-page":"175","article-title":"Progress toward elimination of measles and prevention of congenital rubella infection\u2013European Region, 1990\u20132004","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0140","series-title":"Strategic plan for measles and congenital rubella infection in the WHO European Region","year":"2003"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0145","series-title":"Surveillance guidelines for measles and congenital rubella infection in the WHO European Region","year":"2003"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2016.03.011_bib0150","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/1469-0691.12584","article-title":"The state of measles and rubella in the WHO European Region, 2013","volume":"20","author":"Muscat","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0155","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.vaccine.2014.01.094","article-title":"Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area 2006\u20132011","volume":"32","author":"Colzani","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0160","series-title":"WHO Regional Committee for Europe resolution EUR\/RC60\/R12 on renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region","author":"World Health Organization (WHO) Regional Office for Europe","year":"2010"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0165","series-title":"Global measles & rubella strategic plan 2012\u20132020 [Internet], Geneva","author":"Global Measles & Rubella Strategic Plan 2012\u20132020","year":"2012"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0170","series-title":"Eliminating measles and rubella: framework for the verification process in the WHO European Region","author":"World Health Organization (WHO) Regional Office for Europe","year":"2012"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0175","series-title":"Eliminating measles and rubella: framework for the verification process in the WHO European Region","author":"World Health Organization (WHO) Regional Office for Europe","year":"2014"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0180","unstructured":"Presidency of the Council of Ministers. Rep.n. 66\/Conferenza Stato-Regioni del 23 marzo 2011. Piano nazionale per l\u2019eliminazione del morbillo e della rosolia congenita (PNEMoRc) 2010\u20132015. [Rep. N. 66\/State\u2013Regions Conference of 23 March 2011. Italian national plan for the elimination of measles and congenital rubella (PNEMoRc) 2010-2015. Italian]."},{"issue":"March (3)","key":"10.1016\/j.vaccine.2016.03.011_bib0185","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1586\/14787210.2015.1003808","article-title":"Spotlight on measles in Italy: why outbreaks of a vaccine-preventable infection continue in the 21st century","volume":"13","author":"Piccirilli","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"December (50)","key":"10.1016\/j.vaccine.2016.03.011_bib0190","article-title":"Spotlight on measles 2010: increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010: increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010","volume":"15","author":"Cova","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0195","first-page":"132","article-title":"Epidemiological analysis of measles in the Apulian region based on the use of current data sources","volume":"46","author":"Lopalco","year":"2005","journal-title":"J Prev Med Hyg"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2016.03.011_bib0200","article-title":"An outbreak of measles in Apulia, Italy, November 2006\u2013January 2007","volume":"12","author":"Prato","year":"2007","journal-title":"Euro Surveill"},{"issue":"16","key":"10.1016\/j.vaccine.2016.03.011_bib0205","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.16.18839-en","article-title":"An outbreak of measles including nosocomial transmission in Apulia, south-east Italy, January\u2013March 2008 \u2013 a preliminary report","volume":"13","author":"Caputi","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0210","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1743-422X-4-90","article-title":"Genetic characterization of measles virus strains isolated during an epidemic cluster in Puglia Italy 2006\u20132007","volume":"4","author":"Chironna","year":"2007","journal-title":"Virol J"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2016.03.011_bib0215","article-title":"Letter to the editor: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy","volume":"19","author":"Cozza","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0220","unstructured":"ISTAT. Demography in numbers. Available at demo.istat.it [accessed 20.03.15]."},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2016.03.011_bib0225","first-page":"176","article-title":"Action against vaccine-preventable infectious diseases and tuberculosis in Nomad Camps: the experience of a Local Health Unit in Rome","volume":"26","author":"Spadea","year":"2014","journal-title":"Ann Ig"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0230","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1016\/j.vaccine.2008.05.094","article-title":"Measles serological survey in the Italian population: interpretation of results using mixture model","volume":"26","author":"Rota","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.011_bib0235","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/eurpub\/ckq134","article-title":"Progress towards measles and rubella elimination in Tuscany Italy: the role of population seroepidemiological profile","volume":"22","author":"Bechini","year":"2010","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0240","first-page":"411","article-title":"Seroprevalence of measles-specific antibodies in the group predominantly affected by measles in 2006\u20132009 in Poland","volume":"68","author":"Mak\u00f3wka","year":"2014","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0245","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.011_bib0250","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2458-2-22","article-title":"The average cost of measles cases and adverse events following vaccination in industrialised countries","volume":"2","author":"Carabin","year":"2002","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16003017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16003017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T03:53:41Z","timestamp":1655265221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16003017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":25,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16003017"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}